San Marino, California Clinical Trials

A listing of San Marino, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

This phase III trial studies how well a telehealth self-management program works in improving survivorship care and outcomes in stage I-III non-small cell lung cancer or colorectal cancer survivors. Survivor self-management program focuses on coaching patients on follow-up care after cancer treatments. Participating in the program may improve knowledge and …

stage iiic lung cancer ajcc v8
non-small cell lung cancer
stage iii lung cancer ajcc v8
stage ib lung cancer ajcc v8
stage ia3 lung cancer ajcc v8
City of Hope Medical Center
 (9.7 away) Contact site
  • 4 views
  • 16 Feb, 2024
  • 1 location
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Primary Objective: To determine the maximum tolerated dose (MTD) of SAR442257 administered as a single agent in patients with relapsed and refractory multiple myeloma (RRMM) and refractory non-Hodgkin lymphoma (RR-NHL), and determine the recommended Phase 2 dose (RP2D) Secondary Objectives: To characterize the safety profile of SAR442257 To characterize the …

cancer
cancer therapy
ejection fraction
recurrent disease
excisional biopsy
Investigational Site Number 8400001
 (9.7 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +4 other locations
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

autologous hematopoietic stem cell transplant
monoclonal protein
proteasome inhibitor
cell transplantation
monoclonal antibodies
Investigational Site Number 8400002
 (9.7 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +7 other locations
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

tremor
modafinil
datscan
methyldopa
bradykinesia
Keck School of Medicine of USC
 (7.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +45 other locations
RETHINK REFLUX Registry

The RETHINK REFLUX Registry is a post-market prospective, multi-center, observation, single arm, long-term safety surveillance registry of subjects implanted with the LINX device. The primary objective of the study is to confirm the long-term safety profile of the LINX device and procedure (implant/explant) up to 10 years post-implant.

linx procedure
reflux
Keck Hospital of USC
 (7.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +5 other locations
Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

Nucleix EpiCheck tests analyzes the methylation pattern in a panel of DNA methylation biomarkers and determines whether this pattern is consistent with cancer under test or with non-cancer tissue. This study is being performed as part of the development process of the Pan Cancer EpiCheck test which includes the identification …

cancer
cfdna
Los Angeles Hematology Oncology Medical Group - Wilson Terrace
 (6.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
Pompe Disease Registry Protocol....

The Pompe Registry is a global, multicenter, international, longitudinal, observational, and voluntary program for patients with Pompe disease, designed to track the disease's natural history and outcomes in patients, both treated and not. Data from the Registry are also used to fulfill various global regulatory commitments, to support product development/reimbursement, …

Investigational Site Number :840082
 (7.7 away) Contact site
  • 0 views
  • 14 Mar, 2022
  • +11 other locations
Non Exudative AMD Imaged With SS-OCT- Extension

The investigators wish to better understand the role of the choriocapillaris (CC) in the formation and progression of non-exudative in age related macular degeneration (armd) by imaging the retinal pigment epithelium (rpe) and the choroidal microvasculature and by studying their inter-dependence to determine if the loss of the CC could …

maculopathy
age-related macular degeneration
retinal pigment
drug trials
macular degeneration
University of California Los Angeles Doheny Eye Institute
 (3.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations